AbbVie Docs Not Privileged In Pay-For-Delay Suit, FTC Says
AbbVie Inc. has improperly clawed back documents in a pay-for-delay suit over testosterone replacement treatment AndroGel and wrongly told the court that certain documents are privileged, the Federal Trade Commission told...To view the full article, register now.
Already a subscriber? Click here to view full article